|
 |
|
The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan--Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
This unique worldwide market intelligence and technology assessment report will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in the U....
|
 |
|
$29400.00 |
| |
|
|
|
Future Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies
During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The changes will be caused convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition....
|
|
|
$29400.00 |
| |
|
|
|
The 2011 Clinical Chemistry Market: US, Europe, Japan
During the next decade, the clinical chemistry market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations advances in diagnostic technologies, system engineering, automation, and IT and intensifying competition....
|
|
|
$12500.00 |
| |
|
|
|
The 2011 US Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables....
|
|
|
$10700.00 |
| |
|
|
|
Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies
This report presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:
- Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables....
|
|
|
$10700.00 |
| |
|
|
|
Specialty Testing Markets--The 2010-2014 Forecasts by Assay, Method and Country
This 8-country report presents the 2010-2014 forecasts for thyroid Markers, 25-Hydroxy Vitamin D2 and D3, Immunosuppressants (Tacrolimus, Cyclosporin, Sirolimus, Everolimus, and MPA), Testosterone, Estrogens, and Dihydroxy Vitamin D2 and D3. The report covers Canada, France, Germany, Italy, Japan, Spain, the UK and the US.Contains 77 pages and 48 tables
|
|
|
$8750.00 |
| |
|
|
|
The 2011 Drugs of Abuse Testing Market: US, Europe, Japan
Test Volume and Sales Forecasts by Country and Market Segment
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations advances in diagnostic technologies, system engineering, automation, and IT and intensifying competition....
|
|
|
$7500.00 |
| |
|
|
|
The 2011 Endocrine Function Diagnostics Market: US, Europe, Japan
Test Volume and Sales Forecasts by Country and Market Segment
During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations advances in diagnostic technologies, system engineering, automation, and IT and intensifying competition....
|
|
|
$7500.00 |
| |
|
|
|
The 2011 Immunoprotein Diagnostics Market: US, Europe, Japan
Test Volume and Sales Forecasts by Country and Market Segment
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations advances in diagnostic technologies, system engineering, automation, and IT and intensifying competition....
|
|
|
$7500.00 |
| |
|
|
|
The 2011 Therapeutic Drug Monitoring: US, Europe, Japan
Test Volume and Sales Forecasts by Country and Market Segment
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations advances in diagnostic technologies, system engineering, automation, and IT and intensifying competition....
|
|
|
$7500.00 |
| |
|
|
|
Future Drugs of Abuse Testing Market: US, Europe, Japan
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition....
|
|
|
$7500.00 |
| |
|
|
|
The 2011 Japanese Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the Japanese clinical chemistry and immunodiagnostics markets, including:
- Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Japanese hospitals and commercial laboratories, including controls, calibrators and consumables....
|
|
|
$6800.00 |
| |
|
|
|
The 2011 French Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the French clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in French hospitals and commercial laboratories, including controls, calibrators and consumables....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 German Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the German clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in German hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 Italian Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the Italian clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals and commercial laboratories, including controls, calibrators and consumables....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 Spanish Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the Spanish clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Spanish hospitals, commercial laboratories, and ambulatory care centers, including controls, calibrators and consumables....
|
|
|
$5400.00 |
| |
|
|
|
The 2011 UK Clinical Chemistry and Immunodiagnostics Markets
This report presents a comprehensive analysis of the UK clinical chemistry and immunodiagnostics markets, including:- Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals and commercial laboratories, including controls, calibrators and consumables....
|
|
|
$5400.00 |
| |
|
|
|
Future of Cardiovascular Diagnostics: Impact of Technological Advances on Growth Opportunities and Market Outlook
The report analyzes a variety of cardiac biomarkers currently on the market, including those used to determine cholesterol and lipoprotein levels, cardiac necrosis, thrombosis, inflammation and genetic variants. Furthermore, a large number of biomarkers are currently under evaluation, and if successful, may provide cardiologists with a more comprehensive assessment of cardiovascular risk and prognosis....
|
|
|
$3835.00 |
| |
|
|
|
|